JAGUAR HEALTH, INC. Inventory, Raw Materials, Gross
JAGUAR HEALTH, INC. (JAGX) had Inventory, Raw Materials, Gross of $2.07 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes › Inventory › Inventory, Net
us-gaap:InventoryRawMaterials · last filed 2026-08-19
- 2026-06-30: Inventory, Raw Materials, Gross $2.07M.
- 2026-03-31: Inventory, Raw Materials, Gross $2.06M.
- 2025-12-31: Inventory, Raw Materials, Gross $2.04M.
- 2025-09-30: Inventory, Raw Materials, Gross $1.99M.
| Period end | Inventory, Raw Materials, Gross | Inventory, Raw Materials, Gross as first filed |
|---|---|---|
| 2026-06-30 | $2.07M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $2.06M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $2.04M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $1.99M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.93M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.88M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.85M 10-K · filed 2026-04-07 | |
| 2024-09-30 | $1.90M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.96M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $2.20M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $2.06M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.86M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.00M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $2.13M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.10M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $2.01M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.95M 10-Q · filed 2022-08-22 | |
| 2022-03-31 | $1.56M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $1.25M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $1.21M 10-Q · filed 2021-11-17 | |
| 2021-06-30 | $701.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $790.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.32M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $604.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $631.00K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $551.00K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $457.00K 10-K · filed 2021-03-31 | $457.35K 10-K · filed 2020-04-03 |
| 2018-12-31 | $197.36K 10-K · filed 2020-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |